cannabis indica

Dor — Crônica

termo de indexação original: Pain - Chronic

O acervo do Cannabis Indica reúne 508 estudos científicos que tocam a condição Dor — Crônica, publicados entre 1849 e 2024. Pela leitura automatizada, 400 (79%) foram classificados como favoráveis, 75 (15%) como inconclusivos e 33 (6%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é metanálise (294 estudos), seguido de estudo em animais (62). Os compostos mais presentes são THC Farmacêutico, THC:CBD Farmacêutico e Tetraidrocanabinol (THC). Aparece com frequência ao lado de Dor, Inflamação e Dor — Aguda.

Estudos indexados
508
Período coberto
1849–2024
Favoráveis
400 · 79%
Inconclusivos
75 · 15%
Desfavoráveis
33 · 6%
Termo original
Pain - Chronic

O acervo em números

Tipo de estudo

Metanálise294
Estudo em Animais62
Ensaio Clínico52
Metanálise Clínica45
Ensaio Clínico Duplo-Cego42
Estudo Laboratorial13

Direção do resultado

Favorável400
Inconclusivo75
Desfavorável33

Por década

1840s1
1890s1
1910s1
1970s2
1990s2
2000s31
2010s155
2020s315

Aparece junto com

508 estudos

Filtrar e buscar no acervo →

Esta página mostra 328 dos 508 estudos indexados sobre o tema, dos mais recentes aos mais antigos. Abra o acervo com este filtro para percorrer todos, ou baixe a lista completa em JSON e CSV.

  1. 2024

    An open-label feasibility trial of transdermal cannabidiol for hand osteoarthritis

    FavorávelEnsaio ClínicoDorAnsiedadeArtrite
  2. 2024

    Association between history of cannabis use and outcomes after total hip or knee arthroplasty: a systematic review and meta-analysis

    DesfavorávelMetanáliseDorDor — AgudaCicatrização
  3. 2024

    Cannabis for medical use versus opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised clinical trials

    FavorávelMetanálise ClínicaDorDependência QuímicaDependência — Cannabis+1
  4. 2024

    Effectiveness of Palmitoylethanolamide (Levagen+) Compared to a Placebo for Reducing Pain, Duration, and Medication Use during Migraines in Otherwise Healthy Participants-A Double-Blind Randomised Controlled Study

    FavorávelEnsaio ClínicoDorEnxaquecaPalmitoiletanolamida (PEA)
  5. 2024

    Extended Treatment with Micron-Size Oral Palmitoylethanolamide (PEA) in Chronic Pain: A Systematic Review and Meta-Analysis

    FavorávelMetanálise ClínicaDorPalmitoiletanolamida (PEA)
  6. 2024

    Pharmacokinetics and pharmacodynamics of cannabis-based medicine in a patient population included in a randomized, placebo-controlled, clinical trial

    InconclusivoEnsaio ClínicoDorDoenças NeurodegenerativasEsclerose MúltiplaTetraidrocanabinol (THC)Canabinoide Sintético (não especificado)+2
  7. 2024

    The role of cannabinoids in chronic pain management: clinical insights and challenges

    InconclusivoMetanáliseDorInflamaçãoDor — Neuropatia Periférica+4
  8. 2024

    Δ9-Tetrahydrocannabinol (THC): A Critical Overview of Recent Clinical Trials and Suggested Guidelines for Future Research

    FavorávelMetanálise ClínicaDorDependência QuímicaDependência — CannabisTetraidrocanabinol (THC)THC Farmacêutico+13
  9. 2023

    A Case of Panic Attacks Developing After 10 Years of Chronic Cannabis Use in a Patient With No Prior Psychiatric History

    DesfavorávelMetanáliseDorCâncerInflamaçãoTetraidrocanabinol (THC)Canabigerol (CBG)+13
  10. 2023

    A Phase Ib, Double Blind, Randomized Study of Cannabis Oil for Pain in Parkinson's Disease

    FavorávelEnsaio Clínico Duplo-CegoDorDoença de Parkinson
  11. 2023

    Assessment of Medical Cannabis and Health-Related Quality of Life

    FavorávelMetanáliseDor
  12. 2023

    Associations between Plasma Lipid Mediators and Chronic Daily Headache Outcomes in Patients Randomized to a Low Linoleic Acid Diet with or without Added Omega-3 Fatty Acids

    FavorávelEnsaio ClínicoDorEnxaquecaQualidade de VidaDietaÔmega-3+1
  13. 2023

    Cannabidiol (CBD) Products for Pain: Ineffective, Expensive, and With Potential Harms

    DesfavorávelMetanálise ClínicaDor — AgudaDor — Neuropatia PeriféricaDor — Oncológica+6
  14. 2023

    Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm - A Randomized Pilot Study

    FavorávelEnsaio Clínico Duplo-CegoDorCâncerEpilepsiaTHC FarmacêuticoTHC:CBD Farmacêutico+8
  15. 2023

    Cannabinoid Hyperemesis Syndrome in a 23-Year-Old Woman with Uncontrolled Type 1 Diabetes Mellitus

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisNáusea e VômitoEndocanabinoide (não especificado)+4
  16. 2023

    Cannabinoids versus placebo for pain: A systematic review with meta-analysis and Trial Sequential Analysis

    InconclusivoMetanálise ClínicaDorDependência QuímicaCâncer+15
  17. 2023

    Cannabis use for exercise recovery in trained individuals: a survey study

    FavorávelMetanáliseDorInflamaçãoEfeitos Adversos da CannabisExercício Físico+1
  18. 2023

    Cannabis-Based Medicine for Neuropathic Pain and Spasticity-A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial

    InconclusivoEnsaio Clínico Duplo-CegoDorEsclerose MúltiplaDor — Neuropatia PeriféricaCanabinoide Sintético (não especificado)+2
  19. 2023

    Cannabis-opioid interaction in the treatment of fibromyalgia pain: an open-label, proof of concept study with randomization between treatment groups: cannabis, oxycodone or cannabis/oxycodone combination-the SPIRAL study

    InconclusivoMetanáliseDependência QuímicaDependência — OpioidesFibromialgiaTHC FarmacêuticoTHC:CBD Farmacêutico+1
  20. 2023

    Climbing the Evidence Pyramid: Dosing Considerations for Medical Cannabis in the Management of Chronic Pain

    FavorávelMetanáliseDorTetraidrocanabinol (THC)THC Farmacêutico+2
  21. 2023

    Comparing the effects of medical cannabis for chronic pain patients with and without co-morbid anxiety: A cohort study

    FavorávelMetanáliseDorAnsiedade
  22. 2023

    Dramatic efficacy of cannabidiol on refractory chronic pain in an adolescent with sickle cell disease

    FavorávelMetanáliseDorAnsiedadeDepressãoCanabinoide Sintético (não especificado)CBD Farmacêutico+3
  23. 2023

    Effects of hypnosis, mindfulness meditation, and education for chronic pain on substance use in veterans: A supplementary analysis of a randomized clinical trial

    FavorávelEnsaio ClínicoDorDependência QuímicaDependência — Cannabis+2
  24. 2023

    Efficacy and safety of cannabidiol for the treatment of canine osteoarthritis: a systematic review and meta-analysis of animal intervention studies

    FavorávelMetanáliseDorArtriteQualidade de Vida
  25. 2023

    Efficacy and safety of olorinab, a full agonist of the cannabinoid receptor 2, for the treatment of abdominal pain in patients with irritable bowel syndrome: Results from a phase 2b randomized placebo-controlled trial (CAPTIVATE)

    FavorávelEnsaio Clínico Duplo-CegoDorSíndrome do Intestino IrritávelConstipaçãoEndocanabinoide (não especificado)
  26. 2023

    Electroacupuncture Exerts Analgesic Effects by Restoring Hyperactivity via Cannabinoid Type 1 Receptors in the Anterior Cingulate Cortex in Chronic Inflammatory Pain

    FavorávelEnsaio ClínicoDorAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+1
  27. 2023

    Exploring the therapeutic potential of an antinociceptive and anti-inflammatory peptide from wasp venom

    FavorávelEstudo em AnimaisDorInflamaçãoEpilepsiaEndocanabinoide (não especificado)Canabinoides Sintéticos AM-x+3
  28. 2023

    Health-related quality of life in patients accessing medicinal cannabis in Australia: The QUEST initiative results of a 3-month follow-up observational study

    FavorávelMetanáliseDorAnsiedadeDepressão+2
  29. 2023

    Long-term effects of a diet supplement containing Cannabis sativa oil and Boswellia serrata in dogs with osteoarthritis following physiotherapy treatments: a randomised, placebo-controlled and double-blind clinical trial

    FavorávelEnsaio Clínico Duplo-CegoDorInflamaçãoEstresse Oxidativo+1
  30. 2023

    Medical Cannabinoids as Treatment for Hypophosphatasia-Related Symptoms

    FavorávelMetanáliseDorInflamaçãoSíndrome Metabólica
  31. 2023

    Medical Cannabis Received by Patients According to Qualifying Condition in a US State Cannabis Program: Product Choice, Dosing, and Age-Related Trends

    FavorávelMetanáliseDorCâncerEpilepsiaTHC FarmacêuticoCBD Farmacêutico+16
  32. 2023

    Oral cannabidiol (CBD) as add-on to paracetamol for painful chronic osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial

    InconclusivoEnsaio Clínico Duplo-CegoDorInflamaçãoArtrite
  33. 2023

    Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials

    FavorávelMetanálise ClínicaDorInflamaçãoDor — Neuropatia PeriféricaAnandamida (AEA)Palmitoiletanolamida (PEA)+2
  34. 2023

    The antinociceptive activity and mechanism of action of cannabigerol

    FavorávelEstudo em AnimaisDorInflamaçãoArtriteCanabinoides Sintéticos AM-xCanabigerol (CBG)+5
  35. 2023

    The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence

    FavorávelMetanálise ClínicaDorDependência QuímicaAnsiedade+2
  36. 2023

    The use of cannabidiol as a novel treatment for oral stereotypic behaviour (crib-biting) in a horse

    FavorávelEstudo em AnimaisDorInflamaçãoAnsiedadeEndocanabinoide (não especificado)+12
  37. 2023

    Within-subject, double-blind, randomized, placebo-controlled evaluation of combining the cannabinoid dronabinol and the opioid hydromorphone in adults with chronic pain

    InconclusivoEnsaio Clínico Duplo-CegoDisfunção CognitivaDependência — OpioidesArtriteTHC Farmacêutico
  38. 2022

    A Coala-T-Cannabis Survey Study of breast cancer patients' use of cannabis before, during, and after treatment

    FavorávelMetanáliseDorCâncerAnsiedade+5
  39. 2022

    A mixed methods analysis of cannabis use routines for chronic pain management

    FavorávelMetanáliseDor
  40. 2022

    A narrative review of molecular mechanism and therapeutic effect of Cannabidiol (CBD)

    FavorávelMetanáliseDorCâncerInflamação+5
  41. 2022

    A Randomized Controlled Trial of Topical Cannabidiol for the Treatment of Thumb Basal Joint Arthritis

    FavorávelEnsaio Clínico Duplo-CegoDorArtrite
  42. 2022

    A Review on the Bioactivity of Cannabinoids on Zebrafish Models: Emphasis on Neurodevelopment

    FavorávelMetanáliseDorCâncerAnsiedadeAnandamida (AEA)Tetraidrocanabinol (THC)+25
  43. 2022

    A Systematic Review and Meta-Analysis on the Effects of Exercise on the Endocannabinoid System

    FavorávelMetanáliseDorAnsiedadeDepressãoAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+1
  44. 2022

    An Updated Analysis of Clinical Outcome Measures Across Patients From the UK Medical Cannabis Registry

    FavorávelEnsaio ClínicoDorEfeitos Adversos da CannabisAnsiedade+3
  45. 2022

    Anti-neuropathic pain mechanistic study of A. conyzoides essential oil, Precocene II, Caryophyllene, or Longifolene as single agent and in combination with pregabalin

    FavorávelEstudo em AnimaisDorDor — AgudaDor — Neuropatia Periférica
  46. 2022

    Assessment of Delta-9-Tetrahydrocannabinol (THC) in Saliva and Blood After Oral Administration of Medical Cannabis With Respect to its Effect on Driving Abilities

    DesfavorávelEnsaio ClínicoDorEfeitos Adversos da CannabisTetraidrocanabinol (THC)Ácido Canabidiólico (CBD-a)+1
  47. 2022

    Association of medical cannabis licensure with prescription opioid receipt: A population-based, individual-level retrospective cohort study

    InconclusivoMetanáliseDorDependência — Opioides
  48. 2022

    Cannabidiol as a treatment for arthritis and joint pain: an exploratory cross-sectional study

    FavorávelMetanáliseDorInflamaçãoArtrite+3
  49. 2022

    Cannabidiol attenuates hypersensitivity and oxidative stress after traumatic spinal cord injury in rats

    FavorávelEstudo em AnimaisDorInflamaçãoEstresse Oxidativo+3
  50. 2022

    Cannabidiol for the Management of Endometriosis and Chronic Pelvic Pain

    InconclusivoMetanáliseDorEndometriose
  51. 2022

    Cannabinoid therapeutics in orofacial pain management: a systematic review

    InconclusivoMetanáliseDorCâncerCâncer — Escamoso de Cabeça e PescoçoCanabinoide Sintético (não especificado)THC Farmacêutico+3
  52. 2022

    Cannabinoids for Symptom Management in Patients with Kidney Failure: A Narrative Review

    DesfavorávelMetanáliseDorInflamaçãoAnsiedade+10
  53. 2022

    Cannabinoids in rheumatology: Friend, foe or a bystander?

    InconclusivoMetanáliseDorEpilepsiaEsclerose MúltiplaAnandamida (AEA)Tetraidrocanabinol (THC)+19
  54. 2022

    Cannabinoids in the Orthopedic Setting: A Literature Review

    DesfavorávelMetanáliseDorDependência — OpioidesEsclerose Múltipla+6
  55. 2022

    Cannabinoids reduce opioid use in older patients with pain : Retrospective three-year analysis of data from a general practice

    FavorávelMetanáliseDorTHC FarmacêuticoTHC:CBD Farmacêutico
  56. 2022

    Cannabinoids-Perspectives for Individual Treatment in Selected Patients: Analysis of the Case Series

    FavorávelMetanáliseDorCâncerInflamaçãoAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+13
  57. 2022

    Cannabinol: History, Syntheses, and Biological Profile of the Greatest “Minor” Cannabinoid

    FavorávelMetanáliseDorInflamaçãoDor — AgudaCanabinol (CBN)+5
  58. 2022

    Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis

    InconclusivoMetanálise ClínicaDorPsicoseEsclerose MúltiplaTHC FarmacêuticoTHC:CBD Farmacêutico+1
  59. 2022

    Cannabis and orofacial pain: a systematic review

    FavorávelMetanáliseDorInflamaçãoDor — Neuropatia PeriféricaCanabinoide Sintético (não especificado)+1
  60. 2022

    Cannabis for Medical Use: Versatile Plant Rather Than a Single Drug

    FavorávelMetanáliseDorCâncerInflamaçãoAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+18
  61. 2022

    Cannabis for Rheumatic Disease Pain: a Review of Current Literature

    InconclusivoMetanáliseDorArtriteArtrite — Reumatoide
  62. 2022

    Cannabis Therapies for Low Back Pain: An Observational Open-Label Study

    FavorávelEnsaio ClínicoDor
  63. 2022

    Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain

    InconclusivoMetanáliseDor
  64. 2022

    Cannabis-based medicines and medical cannabis for patients with neuropathic pain and other pain disorders: Nationwide register-based pharmacoepidemiologic comparison with propensity score matched controls

    FavorávelMetanáliseDorDor — Neuropatia PeriféricaDor — Inflamatória
  65. 2022

    Cannabis-Based Products for Chronic Pain : A Systematic Review

    FavorávelMetanálise ClínicaDorInflamaçãoDependência — CannabisTetraidrocanabinol (THC)THC Farmacêutico+7
  66. 2022

    Case Report: Superior Mesenteric Artery Syndrome in an Adolescent With Cannabinoid Hyperemesis

    DesfavorávelMetanáliseDorSíndrome da Hiperêmese Canabinoide
  67. 2022

    Chronic health conditions, acute health events, and healthcare utilization among adults over age 50 in Hawai'i who use cannabis: A matched cohort study

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDoenças Cardiovasculares (DCV)+7
  68. 2022

    Comparison of the Effectiveness and Tolerability of Nabiximols (THC:CBD) Oromucosal Spray versus Oral Dronabinol (THC) as Add-on Treatment for Severe Neuropathic Pain in Real-World Clinical Practice: Retrospective Analysis of the German Pain e-Registry

    FavorávelMetanáliseDorTHC FarmacêuticoTHC:CBD Farmacêutico
  69. 2022

    Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder

    FavorávelEnsaio Clínico Duplo-CegoDorDependência QuímicaDependência — CannabisTetraidrocanabinol (THC)THC:CBD Farmacêutico+3
  70. 2022

    Curcumin induces peripheral antinociception by opioidergic and cannabinoidergic mechanism: Pharmacological evidence

    FavorávelEstudo em AnimaisDorDor — AgudaDor — Neuropatia PeriféricaAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+4
  71. 2022

    Current Cannabidiol Safety: A Review

    FavorávelMetanáliseDorCâncerInflamação+10
  72. 2022

    Cys-loop receptors on cannabinoids: All high?

    FavorávelMetanáliseDorEpilepsia
  73. 2022

    Delta-8-THC: Delta-9-THC’s nicer younger sibling?

    FavorávelMetanáliseDorEfeitos Adversos da CannabisDelta-8-THC
  74. 2022

    Effect of Medical Marijuana Card Ownership on Pain, Insomnia, and Affective Disorder Symptoms in Adults: A Randomized Clinical Trial

    InconclusivoEnsaio ClínicoDorDependência — CannabisAnsiedade+4
  75. 2022

    Effectiveness and Tolerability of Dronabinol Use in Patients with Chronic Pain: A Retrospective Analysis of 12-Week Open-Label Real-World Data Provided by the German Pain e-Registry

    FavorávelMetanáliseDorInsônia e Distúrbios do SonoQualidade de VidaTetraidrocanabinol (THC)THC Farmacêutico
  76. 2022

    Efficacy, Safety, and Regulation of Cannabidiol on Chronic Pain: A Systematic Review

    FavorávelMetanálise ClínicaDor
  77. 2022

    Electroacupuncture Reduces Visceral Pain Via Cannabinoid CB2 Receptors in a Mouse Model of Inflammatory Bowel Disease

    FavorávelEstudo em AnimaisDorDII — Doença Inflamatória IntestinalAcupuntura (MTC)
  78. 2022

    Evaluating the Antinociceptive Efficacy of Cannabidiol Alone or in Combination with Morphine Using the Formalin Test in Male and Female Mice

    InconclusivoEstudo em AnimaisDorDependência — OpioidesDor — Aguda
  79. 2022

    Evaluating the impact of cannabinoids on sleep health and pain in patients with chronic neuropathic pain: a systematic review and meta-analysis of randomized controlled trials

    FavorávelMetanálise ClínicaDorInsônia e Distúrbios do Sono
  80. 2022

    Evidence-based management of multiple sclerosis spasticity with nabiximols oromucosal spray in clinical practice: a 10-year recap

    FavorávelMetanálise ClínicaDorDisfunção CognitivaInsônia e Distúrbios do SonoTetraidrocanabinol (THC)THC:CBD Farmacêutico+1
  81. 2022

    Experience With Medical Marijuana for Cancer Patients in the Palliative Setting

    FavorávelMetanáliseDorCâncerDor — Aguda+2
  82. 2022

    Exploring cannabis use and perspectives among psoriatic disease patients

    InconclusivoEnsaio ClínicoDorArtriteArtrite — Osteoartrite+3
  83. 2022

    G Protein-Coupled Receptors in Osteoarthritis

    FavorávelMetanáliseDorArtriteArtrite — OsteoartriteEndocanabinoide (não especificado)Hidrolase de Amidas de Ácidos Graxos (FAAH)+4
  84. 2022

    Herbal Approaches to Pediatric Functional Abdominal Pain

    InconclusivoMetanáliseDorInflamaçãoEpilepsiaTHC Farmacêutico+10
  85. 2022

    Higher Risk, Higher Reward? Self‐Reported Effects of Real‐World Cannabis Use in Parkinson's Disease

    FavorávelMetanáliseDorAnsiedadeDepressão+2
  86. 2022

    Integrated Medical Cannabis Consultations in a Palliative Care Program: Policies, Procedures, and Progress after Six Years of Practice

    FavorávelMetanáliseDorCâncerDor — Neuropatia Periférica+1
  87. 2022

    Integration of Cannabis Extract Tetrahydrocannabinol:Cannabidiol in an Interdisciplinary Therapy Setting: A Case of Chronic Multilocular Pain Disorder

    FavorávelMetanáliseDorCâncerInflamaçãoTetraidrocanabinol (THC)+10
  88. 2022

    Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model

    FavorávelEstudo em AnimaisDorDor — Neuropatia PeriféricaTHC FarmacêuticoCanabinoides Sintéticos AM-x+1
  89. 2022

    Long-term and serious harms of medical cannabis and cannabinoids for chronic pain: a systematic review of non-randomised studies

    DesfavorávelMetanáliseDorCâncerInflamaçãoAnandamida (AEA)THC Farmacêutico+14
  90. 2022

    Long-term Cannabis-based oil therapy and pain medications prescribing patterns: an Italian observational study

    FavorávelMetanáliseDor
  91. 2022

    Long-term observational studies with cannabis-based medicines for chronic non-cancer pain: A systematic review and meta-analysis of effectiveness and safety

    FavorávelMetanáliseDorAnsiedadeDepressãoHidrolase de Amidas de Ácidos Graxos (FAAH)THC Farmacêutico+5
  92. 2022

    Medical cannabis and cannabinoids for impaired sleep: a systematic review and meta-analysis of randomized clinical trials

    FavorávelMetanálise ClínicaDorInsônia e Distúrbios do Sono
  93. 2022

    Medical Cannabis for Gynecologic Pain Conditions: A Systematic Review

    FavorávelMetanáliseDorCâncerCistite+3
  94. 2022

    Medical cannabis for pain management in patients undergoing chronic hemodialysis: randomized, double-blind, cross-over, feasibility study

    FavorávelEnsaio Clínico Duplo-CegoDorInsuficiência RenalTetraidrocanabinol (THC)
  95. 2022

    Medical cannabis use by rheumatology patients in routine clinical care: results from The Ontario Best Practices Research Initiative

    DesfavorávelMetanáliseDorAnsiedadeArtrite+2
  96. 2022

    Medical Cannabis Use Reduces Opioid Prescriptions in Patients With Chronic Back Pain

    FavorávelMetanáliseDor
  97. 2022

    Medical Cannabis Use Reduces Opioid Prescriptions in Patients With Osteoarthritis

    FavorávelEnsaio ClínicoDorDependência — OpioidesArtrite+1
  98. 2022

    Medical Cannabis Used as an Alternative Treatment for Chronic Pain Demonstrates Reduction in Chronic Opioid Use - A Prospective Study

    FavorávelMetanáliseDorDependência — Opioides
  99. 2022

    Medical Marijuana Efficacy: A Survey

    FavorávelMetanáliseDorInflamaçãoAnsiedade+3
  100. 2022

    Medicinal Cannabis for the Treatment of Chronic Refractory Pain: An Investigation of the Adverse Event Profile and Health-Related Quality of Life Impact of an Oral Formulation

    FavorávelEnsaio ClínicoDorTHC:CBD Farmacêutico
  101. 2022

    Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial

    FavorávelEnsaio Clínico Duplo-CegoDorDependência QuímicaEfeitos Adversos da CannabisTetraidrocanabinol (THC)THC:CBD Farmacêutico+2
  102. 2022

    Non-psychotropic phytocannabinoid interactions with voltage-gated sodium channels: An update on cannabidiol and cannabigerol

    FavorávelMetanáliseDorDor — AgudaCanabigerol (CBG)
  103. 2022

    Nonpharmacologic management of chronic pain in the United States’ Medicare population: a scoping review protocol

    DesfavorávelMetanáliseDor
  104. 2022

    Oral capsules of tetra-hydro-cannabinol (THC), cannabidiol (CBD) and their combination in peripheral neuropathic pain treatment

    DesfavorávelEnsaio Clínico Duplo-CegoDorPsicoseDor — Neuropatia Periférica+3
  105. 2022

    Pentadecanoylcarnitine is a newly discovered endocannabinoid with pleiotropic activities relevant to supporting physical and mental health

    FavorávelEstudo em AnimaisDorInflamaçãoAnsiedadeÁcido Pentadecanoico (C15:0)Pentadecanoilcarnitina (PDC)+2
  106. 2022

    Pharmacokinetics, Safety, and Tolerability of a Medicinal Cannabis Formulation in Patients with Chronic Non-cancer Pain on Long-Term High Dose Opioid Analgesia: A Pilot Study

    FavorávelEnsaio ClínicoDorDependência — OpioidesTetraidrocanabinol (THC)
  107. 2022

    Pharmacological effects of cannabidiol by transient receptor potential channels

    FavorávelMetanáliseDorCâncerInflamação+5
  108. 2022

    Pilot clinical and pharmacokinetic study of Δ9-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain

    FavorávelEnsaio ClínicoDorCâncerInsônia e Distúrbios do SonoCanabinol (CBN)Ácido Canabidiólico (CBD-a)+6
  109. 2022

    Potential use for chronic pain: Poly(Ethylene Glycol)-Poly(Lactic-Co-Glycolic Acid) nanoparticles enhance the effects of Cannabis-Based terpenes on calcium influx in TRPV1-Expressing cells

    FavorávelEstudo LaboratorialDor
  110. 2022

    Predictors of pain reduction among fibromyalgia patients using medical cannabis: a long-term prospective cohort study

    FavorávelEnsaio ClínicoDorAnsiedadeDepressão+2
  111. 2022

    Pregnant People's Perspectives On Cannabis Use During Pregnancy: A Systematic Review and Integrative Mixed-Methods Research Synthesis

    FavorávelMetanáliseDorDependência QuímicaEfeitos Adversos da Cannabis+7
  112. 2022

    Prevalence and correlates of cannabis use disorder among Australians using cannabis products to treat a medical condition

    DesfavorávelMetanáliseDorDependência QuímicaCâncerTetraidrocanabinol (THC)+12
  113. 2022

    Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada

    FavorávelMetanáliseDorDepressãoPsicose+5
  114. 2022

    Randomised, pragmatic, waitlist controlled trial of cannabis added to prescription opioid support on opioid dose reduction and pain in adults with chronic non-cancer pain: study protocol

    InconclusivoMetanáliseDorDependência — OpioidesTHC FarmacêuticoTHC:CBD Farmacêutico
  115. 2022

    Recreational cannabis legalizations associated with reductions in prescription drug utilization among Medicaid enrollees

    FavorávelMetanáliseDorAnsiedadeDepressão+3
  116. 2022

    Role of Cannabinoids in Various Diseases: A Review

    FavorávelMetanáliseDorInflamaçãoPsicoseEndocanabinoide (não especificado)+9
  117. 2022

    Routes of administration, reasons for use, and approved indications of medical cannabis in oncology: a scoping review

    FavorávelMetanáliseDorCâncerNáusea e Vômito+1
  118. 2022

    Self-Reported Cannabis Use Is Associated With a Lower Rate of Persistent Opioid Use After Total Joint Arthroplasty

    FavorávelMetanáliseDorDependência QuímicaDependência — Opioides+1
  119. 2022

    Sex differences in medical cannabis-related adverse effects

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDor — AgudaCanabigerol (CBG)Canabinol (CBN)+2
  120. 2022

    Spinal cannabinoid CB1 or CB2 receptors activation attenuates mechanical allodynia in streptozotocin-induced diabetic rats

    FavorávelEstudo em AnimaisDorDiabetesSíndrome MetabólicaEndocanabinoide (não especificado)Canabinoides Sintéticos AM-x+3
  121. 2022

    Systematic reviews of randomized controlled trials of cannabinoid products in chronic pain conditions and for symptoms associated with multiple sclerosis: what do they tell us?

    InconclusivoMetanálise ClínicaDorEsclerose MúltiplaDor — Neuropatia Periférica+1
  122. 2022

    Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome

    FavorávelMetanáliseDorInflamaçãoDor — AgudaAnandamida (AEA)Endocanabinoide (não especificado)+2
  123. 2022

    The C4EB study-Transvamix (10% THC / 5% CBD) to treat chronic pain in epidermolysis bullosa: A protocol for an explorative randomized, placebo controlled, and double blind intervention crossover study

    InconclusivoMetanáliseDorEpidermólise BolhosaTHC:CBD Farmacêutico
  124. 2022

    The Characteristics of Clinical Trials on Cannabis and Cannabinoids: A Review of Trials for Therapeutic or Drug Development Purposes

    FavorávelMetanálise ClínicaDorCâncerAnsiedade+5
  125. 2022

    The effect of medical cannabis on cognitive functions: a systematic review

    DesfavorávelMetanálise ClínicaDorCâncerEfeitos Adversos da CannabisTHC:CBD FarmacêuticoCBD Farmacêutico+11
  126. 2022

    The Effectiveness and Safety of Pharmaceutical-Grade Cannabidiol in the Treatment of Mastocytosis-Associated Pain: A Pilot Study

    FavorávelEnsaio ClínicoDorAnsiedadeDepressão+3
  127. 2022

    The Efficacy of Cannabis in Reducing Back Pain: A Systematic Review

    FavorávelMetanálise ClínicaDorTetraidrocanabinol (THC)THC Farmacêutico
  128. 2022

    The intersection between integrative medicine and neuropathic pain: A case report

    FavorávelMetanáliseDorAnsiedadeInsônia e Distúrbios do SonoMedicina Mente-CorpoAcupuntura (MTC)+2
  129. 2022

    Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals

    FavorávelMetanáliseDorDependência — CannabisEpilepsiaTHC FarmacêuticoTHC:CBD Farmacêutico+9
  130. 2022

    TRPV1: A Common Denominator Mediating Antinociceptive and Antiemetic Effects of Cannabinoids

    FavorávelMetanáliseDorInflamaçãoEfeitos Adversos da CannabisAnandamida (AEA)Endocanabinoide (não especificado)+18
  131. 2022

    Use of cannabis in the treatment of animals: a systematic review of randomized clinical trials

    FavorávelMetanálise ClínicaDorEpilepsiaTranstornos de Comportamento+3
  132. 2021

    "Less pain with more gain"-Managing wound-related pain with cannabis-based medicines

    FavorávelMetanáliseDorCicatrização
  133. 2021

    [Cannabis and cannabinoids for the treatment of acute and chronic pain]

    InconclusivoMetanáliseDorDor — Aguda
  134. 2021

    A cannabis oracle? Delphi method not a substitute for randomized controlled trials of cannabinoids as therapeutics

    DesfavorávelMetanáliseDor
  135. 2021

    A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019

    InconclusivoMetanáliseDorCâncerEpilepsiaTHC FarmacêuticoCBD Farmacêutico+9
  136. 2021

    A pain killer without analgesic tolerance designed by co-targeting PSD-95-nNOS interaction and α2-containning GABA A Rs

    FavorávelEstudo em AnimaisDor
  137. 2021

    A Survey of Cannabis Use in a Large US-Based Cohort of People with Multiple Sclerosis

    InconclusivoMetanáliseDorAnsiedadeInsônia e Distúrbios do Sono+1
  138. 2021

    A Survey on the Effect That Medical Cannabis Has on Prescription Opioid Medication Usage for the Treatment of Chronic Pain at Three Medical Cannabis Practice Sites

    FavorávelMetanáliseDorDependência — Opioides
  139. 2021

    A systematic review and meta-analysis of cannabis-based medicines, cannabinoids and endocannabinoid system modulators tested for antinociceptive effects in animal models of injury-related or pathological persistent pain

    FavorávelMetanáliseDorDor — Neuropatia PeriféricaDor — NociceptivaOutros Compostos Relacionados+1
  140. 2021

    A Systematic Review of Assessments and Interventions for Chronic Pain in Young Children With or at High Risk for Cerebral Palsy

    InconclusivoMetanáliseDorEfeitos Adversos da CannabisParalisia Cerebral
  141. 2021

    A validated method for the simultaneous quantification of cannabidiol, Δ9 -tetrahydrocannabinol, and their metabolites in human plasma and application to plasma samples from an oral cannabidiol open-label trial

    FavorávelEstudo LaboratorialAnsiedadeEpilepsiaCanabicromeno (CBC)
  142. 2021

    Adjunctive Management of Opioid Withdrawal with the Nonopioid Medication Cannabidiol

    FavorávelMetanáliseDorDependência QuímicaInflamação+7
  143. 2021

    Adverse Effects of Recreational and Medical Cannabis

    InconclusivoMetanáliseDorEfeitos Adversos da CannabisDependência — Cannabis+1
  144. 2021

    Adverse Effects of Recreational and Medical Cannabis

    InconclusivoMetanáliseDorEfeitos Adversos da CannabisDoenças Neurodegenerativas+2
  145. 2021

    Analgesic Potential of Terpenes Derived from Cannabis sativa

    FavorávelMetanáliseDorCâncerInflamaçãoEquinácea+5
  146. 2021

    Antinociception mechanisms of action of cannabinoid-based medicine: an overview for anesthesiologists and pain physicians

    FavorávelMetanáliseDorInflamaçãoDor — Aguda+1
  147. 2021

    Antinociceptive and Anti-Inflammatory Properties of Cannabidiol Alone and in Combination with Standardized Bioflavonoid Composition

    FavorávelEstudo em AnimaisDorInflamaçãoDor — Aguda
  148. 2021

    Antinociceptive effects of minor cannabinoids, terpenes and flavonoids in Cannabis

    FavorávelMetanáliseDorDor — Aguda
  149. 2021

    Archaeobotanical evidence of the use of medicinal cannabis in a secular context unearthed from South China

    FavorávelMetanáliseDorArtriteArtrite — Osteoartrite+1
  150. 2021

    Are Cannabis, Cannabis-Derived Products, and Synthetic Cannabinoids a Therapeutic Tool for Rheumatoid Arthritis? A Friendly Summary of the Body of Evidence

    InconclusivoMetanáliseDorEfeitos Adversos da CannabisArtriteCanabinoide Sintético (não especificado)+2
  151. 2021

    Calling for Openness to the Study of Cannabis Use in Chronic Pelvic Pain

    FavorávelMetanáliseDor
  152. 2021

    Can Cannabidiol Affect the Efficacy of Chemotherapy and Epigenetic Treatments in Cancer?

    FavorávelMetanáliseDorCâncerInflamaçãoCBD Farmacêutico+5
  153. 2021

    Can Medical Cannabis Therapies be Cost-Effective in the Non-Surgical Management of Chronic Knee Pain?

    FavorávelMetanáliseDor
  154. 2021

    Cannabidiol (CBD) Use by Older Adults for Acute and Chronic Pain

    FavorávelMetanáliseDor
  155. 2021

    Cannabidiol as a Treatment for Chronic Pain: A Survey of Patients’ Perspectives and Attitudes

    FavorávelEnsaio ClínicoDor
  156. 2021

    Cannabidiol effectively reverses mechanical and thermal allodynia, hyperalgesia, and anxious behaviors in a neuropathic pain model: Possible role of CB1 and TRPV1 receptors

    FavorávelEstudo em AnimaisDorAnsiedadeDor — Aguda+1
  157. 2021

    Cannabidiol for Mood Disorders: A Call for More Research

    DesfavorávelMetanáliseDorDepressãoDisfunção Cognitiva+3
  158. 2021

    Cannabidiol in low back pain: scientific rationale for clinical trials in low back pain

    FavorávelMetanáliseDorDor — Aguda
  159. 2021

    Cannabidiol in the prelimbic cortex modulates the comorbid condition between the chronic neuropathic pain and depression-like behaviour in rats: The role of medial prefrontal cortex 5-HT 1A and CB 1 receptors

    FavorávelEstudo em AnimaisDorDepressãoEndocanabinoide (não especificado)Canabinoides Sintéticos AM-x
  160. 2021

    Cannabidiol microinjection into the nucleus accumbens attenuated nociceptive behaviors in an animal model of tonic pain

    FavorávelEstudo em AnimaisDorInflamação
  161. 2021

    Cannabidiol Use, Substitution for Medications, and Perceptions of Effectiveness in Women with Chronic Pelvic Pain

    FavorávelMetanáliseDorEfeitos Adversos da CannabisAnsiedade+8
  162. 2021

    Cannabidiol-based natural health products for companion animals: Recent advances in the management of anxiety, pain, and inflammation

    FavorávelMetanáliseDorInflamaçãoAnsiedade+4
  163. 2021

    Cannabidiol: pharmacology and therapeutic targets

    FavorávelMetanáliseDorInflamaçãoEpilepsia+4
  164. 2021

    Cannabinoid and Opioid Use Among Total Joint Arthroplasty Patients: A 6-Year, Single-Institution Study

    FavorávelMetanáliseDorDependência QuímicaDependência — Opioides+2
  165. 2021

    Cannabinoid receptor agonists from Conus venoms alleviate pain-related behavior in rats

    FavorávelEstudo em AnimaisDor
  166. 2021

    Cannabinoid Use in a Tertiary Headache Clinic: A Cross-Sectional Survey

    FavorávelMetanáliseDor
  167. 2021

    Cannabinoids and bladder symptoms in multiple sclerosis

    FavorávelMetanáliseDorAnsiedadeDepressão+4
  168. 2021

    Cannabinoids and Pain: The Highs and Lows

    FavorávelMetanáliseDor
  169. 2021

    Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials

    InconclusivoMetanálise ClínicaDorDor — AgudaDor — Neuropatia PeriféricaTHC FarmacêuticoTHC:CBD Farmacêutico+5
  170. 2021

    Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews

    InconclusivoMetanálise ClínicaDorDor — AgudaDor — Neuropatia Periférica+4
  171. 2021

    Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies

    FavorávelMetanáliseDorDor — Neuropatia PeriféricaDor — Nociceptiva+1
  172. 2021

    Cannabis and pain: a scoping review

    InconclusivoMetanáliseDorDor — AgudaDor — Oncológica
  173. 2021

    Cannabis and the skin

    FavorávelMetanáliseDorCâncerInflamação+10
  174. 2021

    Cannabis Dopaminergic Effects Induce Hallucinations in a Patient with Parkinson's Disease

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDisfunção CognitivaTHC Farmacêutico+4
  175. 2021

    Cannabis for Chronic Osteoarthritis Pain: A Case of an Older Person

    FavorávelMetanáliseDorArtriteArtrite — Osteoartrite+1
  176. 2021

    Cannabis for Chronic Pain: A Rapid Systematic Review of Randomized Control Trials

    FavorávelMetanálise ClínicaDor
  177. 2021

    Cannabis Significantly Reduces the Use of Prescription Opioids and Improves Quality of Life in Authorized Patients: Results of a Large Prospective Study

    FavorávelMetanáliseDorDependência QuímicaDependência — Opioides
  178. 2021

    Cannabis use, pain interference, and prescription opioid receipt among persons with HIV: a target trial emulation study

    InconclusivoMetanáliseDorDependência — OpioidesHIV/AIDS
  179. 2021

    Cannabis-based medicines and pain: a review of potential synergistic and entourage effects

    FavorávelMetanáliseDorDor — Aguda
  180. 2021

    Chronic Treatment with Cannabidiolic Acid (CBDA) Reduces Thermal Pain Sensitivity in Male Mice and Rescues the Hyperalgesia in a Mouse Model of Rett Syndrome

    FavorávelEstudo em AnimaisDorAnsiedadeDisfunção CognitivaÁcido Canabidiólico (CBD-a)+4
  181. 2021

    Clinical outcome data of first cohort of chronic pain patients treated with cannabis-based sublingual oils in the United Kingdom - analysis from the UK Medical Cannabis Registry

    FavorávelMetanáliseDorInsônia e Distúrbios do Sono
  182. 2021

    Components of the Endogenous Cannabinoid System as Potential Biomarkers for Interstitial Cystitis/Bladder Pain Syndrome

    FavorávelMetanáliseDorCistiteEndocanabinoide (não especificado)
  183. 2021

    Consensus-based recommendations for titrating cannabinoids and tapering opioids for chronic pain control

    FavorávelMetanáliseDorDependência — Opioides
  184. 2021

    Consumer Experiences with Delta-8-THC: Medical Use, Pharmaceutical Substitution, and Comparisons with Delta-9-THC

    FavorávelMetanáliseDorAnsiedadeDepressãoDelta-8-THC+1
  185. 2021

    Cost-Effectiveness of Medicinal Cannabis for Management of Refractory Symptoms Associated With Chronic Conditions: A Systematic Review of Economic Evaluations

    FavorávelMetanáliseDorEpilepsiaEsclerose MúltiplaTHC FarmacêuticoTHC:CBD Farmacêutico+7
  186. 2021

    Demographics, Perceptions, and Use of Medical Marijuana among Patients in Florida

    FavorávelMetanáliseDorAnsiedade
  187. 2021

    Design of Negative and Positive Allosteric Modulators of the Cannabinoid CB 2 Receptor Derived from the Natural Product Cannabidiol

    FavorávelEstudo LaboratorialDorInflamaçãoEfeitos Adversos da Cannabis+2
  188. 2021

    Developing a real-world evidence base for prescribed cannabis in the United Kingdom: preliminary findings from Project Twenty21

    FavorávelMetanáliseDorAnsiedadeDepressão+1
  189. 2021

    Dose-Related Inhibition of Capsaicin Responses by Cannabinoids CBG, CBD, THC and their Combination in Cultured Sensory Neurons

    FavorávelEstudo LaboratorialDorDor — AgudaCanabigerol (CBG)Canabicromeno (CBC)+1
  190. 2021

    Effect of Ultra-Micronized-Palmitoylethanolamide and Acetyl-l-Carnitine on Experimental Model of Inflammatory Pain

    FavorávelEstudo em AnimaisDorInflamaçãoEstresse OxidativoEndocanabinoide (não especificado)Palmitoiletanolamida (PEA)+2
  191. 2021

    Effectiveness, safety and tolerability of nabiximols oromucosal spray versus typical oral long-acting opioid analgesics in patients with severe neuropathic back pain: analysis of 6-month real-world data from the German Pain e-Registry

    FavorávelMetanáliseDorDor — Neuropatia PeriféricaTHC:CBD Farmacêutico
  192. 2021

    Efficacy of a fixed combination of palmitoylethanolamide and acetyl-l-carnitine (PEA+ALC FC) in the treatment of neuropathies secondary to rheumatic diseases

    FavorávelEnsaio ClínicoDorInflamaçãoDor — Neuropatia PeriféricaPalmitoiletanolamida (PEA)+3
  193. 2021

    Efficacy of cannabis-based medications compared to placebo for the treatment of chronic neuropathic pain: a systematic review with meta-analysis

    FavorávelMetanálise ClínicaDorTHC FarmacêuticoTHC:CBD Farmacêutico+1
  194. 2021

    Emerging role of cannabinoids and synthetic cannabinoid receptor 1/cannabinoid receptor 2 receptor agonists in cancer treatment and chemotherapy-associated cancer management

    FavorávelMetanáliseDorCâncerAnsiedade+4
  195. 2021

    Evaluation of Patient Reported Safety and Efficacy of Cannabis From a Survey of Medical Cannabis Patients in Canada

    FavorávelMetanáliseDorInsônia e Distúrbios do SonoArtrite+3
  196. 2021

    Evaluation of the Effect of Cannabidiol on Naturally Occurring Osteoarthritis-Associated Pain: A Pilot Study in Dogs

    InconclusivoEstudo em AnimaisDorArtriteArtrite — Osteoartrite
  197. 2021

    Evaluation of the terpenes β-caryophyllene, α-terpineol, and γ-terpinene in the mouse chronic constriction injury model of neuropathic pain: possible cannabinoid receptor involvement

    FavorávelEstudo em AnimaisDor
  198. 2021

    Exercise in Treatment of Migraine Including Chronic Migraine

    FavorávelMetanáliseDorEnxaquecaExercício Físico
  199. 2021

    Experimental therapies in Irritable Bowel Syndrome

    FavorávelMetanáliseDorInflamaçãoDor — AgudaAnandamida (AEA)Endocanabinoide (não especificado)+4
  200. 2021

    GABA- and Glycine-Mimetic Responses of Linalool on the Substantia Gelatinosa of the Trigeminal Subnucleus Caudalis in Juvenile Mice: Pain Management through Linalool-Mediated Inhibitory Neurotransmission

    FavorávelEstudo em AnimaisDor
  201. 2021

    General risks of harm with cannabinoids, cannabis, and cannabis-based medicine possibly relevant to patients receiving these for pain management: an overview of systematic reviews

    InconclusivoMetanáliseDor
  202. 2021

    GPR119 and GPR55 as Receptors for Fatty Acid Ethanolamides, Oleoylethanolamide and Palmitoylethanolamide

    FavorávelMetanáliseDorInflamaçãoObesidadePalmitoiletanolamida (PEA)+2
  203. 2021

    Healing of a Chronic Pressure Injury in a Patient Treated With Medical Cannabis for Pain and Sleep Improvement: A Case Report

    FavorávelMetanáliseDorInsônia e Distúrbios do SonoCicatrização+1
  204. 2021

    Health Outcomes among Adults Initiating Medical Cannabis for Chronic Pain: A 3-month Prospective Study Incorporating Ecological Momentary Assessment (EMA)

    FavorávelMetanáliseDor
  205. 2021

    High and Mighty? Cannabinoids and the microbiome in pain

    FavorávelMetanáliseDorInflamaçãoDor — AgudaEndocanabinoide (não especificado)Microbioma
  206. 2021

    Human Laboratory Models of Cannabis Use: Applications for Clinical and Translational Psychiatry Research

    FavorávelMetanáliseDorDependência QuímicaCâncer+16
  207. 2021

    Improved Bioavailability with Dry Powder Cannabidiol Inhalation: A Phase 1 Clinical Study

    FavorávelEnsaio ClínicoDorAnsiedadeEpilepsiaCBD Farmacêutico+3
  208. 2021

    Interim Results of the Survey Accompanying the Prescription of Cannabis-Based Medicines in Germany Regarding Dronabinol

    FavorávelMetanáliseDorTHC Farmacêutico
  209. 2021

    International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management

    FavorávelMetanáliseDorDor — AgudaDor — Neuropatia Periférica+5
  210. 2021

    Limonene, a citrus monoterpene, non-complexed and complexed with hydroxypropyl-β-cyclodextrin attenuates acute and chronic orofacial nociception in rodents: Evidence for involvement of the PKA and PKC pathway

    FavorávelEstudo em AnimaisDorDor — Aguda
  211. 2021

    Measuring the Change in Health-Related Quality of Life in Patients Using Marijuana for Pain Relief

    FavorávelMetanáliseDor
  212. 2021

    Medical Cannabis as a Substitute for Prescription Agents: A Systematic Review and Meta-analysis

    FavorávelMetanáliseDorAnsiedadeDepressão
  213. 2021

    Medical Cannabis Certification Is Associated With Decreased Opiate Use in Patients With Chronic Pain: A Retrospective Cohort Study in Delaware

    FavorávelMetanáliseDorDependência QuímicaDependência — Opioides
  214. 2021

    Medical Cannabis for Chronic Noncancer Pain: A Systematic Review of Health Care Recommendations

    FavorávelMetanáliseDorHIV/AIDS
  215. 2021

    Medical Cannabis for Headache Pain: a Primer for Clinicians

    FavorávelMetanáliseDorDependência — OpioidesEnxaqueca
  216. 2021

    Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials

    InconclusivoMetanálise ClínicaDorInsônia e Distúrbios do SonoDor — Oncológica
  217. 2021

    Medical cannabis treatment for chronic pain: Outcomes and prediction of response

    FavorávelMetanáliseDor
  218. 2021

    Medical Cannabis Use Among Older Adults in Canada: Self-Reported Data on Types and Amount Used, and Perceived Effects

    FavorávelMetanáliseDorCâncerAnsiedade+5
  219. 2021

    Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A New Route in the Fight Against COVID-19?

    FavorávelMetanáliseDorCâncerDoenças Neurodegenerativas+5
  220. 2021

    Mixed methods study of the potential therapeutic benefits from medical cannabis for patients in Florida

    FavorávelMetanáliseDorDepressãoEpilepsia+6
  221. 2021

    Modulation of Noradrenergic and Serotonergic Systems by Cannabinoids: Electrophysiological, Neurochemical and Behavioral Evidence

    FavorávelMetanáliseDorAnsiedadeInsônia e Distúrbios do Sono+1
  222. 2021

    Morphine Induces Upregulation of Neuronally Expressed CB2 Receptors in the Spinal Dorsal Horn of Rats

    FavorávelEstudo em AnimaisDor
  223. 2021

    Nabiximols in Chronic Neuropathic Pain: A Meta-Analysis of Randomized Placebo-Controlled Trials

    FavorávelMetanálise ClínicaDorTHC:CBD Farmacêutico
  224. 2021

    Natural and Synthetic Cannabinoids: Pharmacology, Uses, Adverse Drug Events, and Drug Interactions

    DesfavorávelMetanáliseDorDependência QuímicaEfeitos Adversos da Cannabis2-Araquidonoilglicerol (2-AG)Canabinoide Sintético (não especificado)+24
  225. 2021

    Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review

    InconclusivoMetanáliseDorAnsiedadePsicose+3
  226. 2021

    No pain, all gain? Interim analyses from a longitudinal, observational study examining the impact of medical cannabis treatment on chronic pain and related symptoms

    FavorávelMetanáliseDorAnsiedadeInsônia e Distúrbios do Sono
  227. 2021

    Novel CBG Derivatives Can Reduce Inflammation, Pain and Obesity

    FavorávelEstudo em AnimaisDorInflamaçãoObesidadeCanabigerol (CBG)
  228. 2021

    Opioid and healthcare service use in medical cannabis patients with chronic pain: a prospective study

    FavorávelMetanáliseDorDependência — Opioides
  229. 2021

    Opioid Prescribing in Canada following the Legalization of Cannabis: A Clinical and Economic Time-Series Analysis

    FavorávelMetanáliseDorDependência — Opioides
  230. 2021

    Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada

    FavorávelMetanáliseDorDependência QuímicaDependência — Opioides
  231. 2021

    Opioid-sparing effects of medical cannabis or cannabinoids for chronic pain: a systematic review and meta-analysis of randomised and observational studies

    InconclusivoMetanáliseDorDependência — OpioidesInsônia e Distúrbios do Sono+3
  232. 2021

    Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model

    FavorávelEstudo em AnimaisDorDor — Neuropatia Periférica
  233. 2021

    Orally Active Peptide Vector Allows Using Cannabis to Fight Pain While Avoiding Side Effects

    FavorávelEstudo LaboratorialDor
  234. 2021

    Pain Profiles among Young Adult Cannabis Users: An Analysis of Antecedent Factors and Distal Outcomes

    FavorávelMetanáliseDorInsônia e Distúrbios do SonoDor — Aguda
  235. 2021

    Pain, cannabis use, and physical and mental health indicators among veterans and nonveterans: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III

    DesfavorávelMetanáliseDorDependência — CannabisAnsiedade+2
  236. 2021

    Palmitoylethanolamide and hemp oil extract exert synergistic anti-nociceptive effects in mouse models of acute and chronic pain

    FavorávelEstudo em AnimaisDorDor — Aguda
  237. 2021

    Palmitoylethanolamide: A Natural Compound for Health Management

    FavorávelMetanáliseDorInflamaçãoInfecções BacterianasPalmitoiletanolamida (PEA)
  238. 2021

    Patient-reported outcomes in those consuming medical cannabis: a prospective longitudinal observational study in chronic pain patients

    FavorávelMetanáliseDor
  239. 2021

    Perceived Efficacy, Reduced Prescription Drug Use, and Minimal Side Effects of Cannabis in Patients with Chronic Orthopedic Pain

    FavorávelMetanáliseDor
  240. 2021

    Perspectives of pediatric oncologists and palliative care physicians on the therapeutic use of cannabis in children with cancer

    FavorávelMetanáliseDorCâncerDepressão+7
  241. 2021

    Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition

    FavorávelMetanáliseDorInflamaçãoEpilepsiaAnandamida (AEA)Endocanabinoide (não especificado)+14
  242. 2021

    Practical Strategies Using Medical Cannabis to Reduce Harms Associated With Long Term Opioid Use in Chronic Pain

    FavorávelMetanáliseDorDependência — Opioides
  243. 2021

    Prevalence and impact of comorbid chronic pain and cigarette smoking among people living with HIV

    DesfavorávelMetanáliseDorDependência — CannabisHIV/AIDS
  244. 2021

    Prevalence of Cannabidiol Use in Patients With Spine Complaints: Results of an Anonymous Survey

    FavorávelMetanáliseDorAnsiedadeInsônia e Distúrbios do Sono+2
  245. 2021

    Progression of cannabis withdrawal symptoms in people using medical cannabis for chronic pain

    DesfavorávelMetanáliseDorDependência QuímicaDependência — Cannabis
  246. 2021

    Prolonged Medical Cannabis Treatment is Associated With Quality of Life Improvement and Reduction of Analgesic Medication Consumption in Chronic Pain Patients

    FavorávelMetanáliseDorDependência — Opioides
  247. 2021

    Quality of Life and a Surveillant Endocannabinoid System

    FavorávelMetanáliseDorInflamaçãoDoenças NeurodegenerativasEndocanabinoide (não especificado)Medicina Mente-Corpo+1
  248. 2021

    Risk and benefit of cannabis prescription for chronic non-cancer pain

    FavorávelMetanáliseDorDependência QuímicaDependência — Opioides
  249. 2021

    Safety and tolerability of escalating cannabinoid doses in healthy cats

    FavorávelEstudo em AnimaisDorEfeitos Adversos da CannabisEpilepsiaÁcido Canabidiólico (CBD-a)+3
  250. 2021

    Safety and tolerability of nabiximols oromucosal spray: a review of more than 15 years" accumulated evidence from clinical trials

    FavorávelMetanálise ClínicaDorDoenças NeurodegenerativasEsclerose MúltiplaTHC:CBD Farmacêutico+5
  251. 2021

    Safety and tolerability of nabiximols oromucosal spray: a review of real-world experience in observational studies, registries, and case reports

    FavorávelMetanáliseDorDoenças NeurodegenerativasEsclerose MúltiplaTHC:CBD Farmacêutico+1
  252. 2021

    Should You Recommend Cannabinoids for This Patient With Painful Neuropathy? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center

    FavorávelMetanáliseDor
  253. 2021

    Specific phytocannabinoid compositions are associated with analgesic response and adverse effects in chronic pain patients treated with medical cannabis

    InconclusivoMetanáliseDor
  254. 2021

    Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms

    FavorávelMetanáliseDorAnsiedadeDepressãoCanabigerol (CBG)+1
  255. 2021

    Tetrahydrocannabinol and cannabidiol as an oromucosal spray in a 1:1 ratio: a therapeutic option for patients with central post-stroke pain syndrome?

    FavorávelMetanáliseDorAVCDor — Síndrome da Dor CentralTHC:CBD Farmacêutico
  256. 2021

    The cannabinoid system and microglia in health and disease

    FavorávelMetanáliseDorInflamaçãoAnsiedadeAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+7
  257. 2021

    The Effect of Medical Cannabis on Pain Level and Quality of Sleep among Rheumatology Clinic Outpatients

    FavorávelMetanáliseDorInflamaçãoEfeitos Adversos da Cannabis+8
  258. 2021

    The Effectiveness of Cannabis and Cannabis Derivatives in Treating Lower Back Pain in the Aged Population: A Systematic Review

    InconclusivoMetanáliseDorAnsiedadeInsônia e Distúrbios do SonoTHC FarmacêuticoCBD Farmacêutico+2
  259. 2021

    The Efficacy, Adverse Events, and Withdrawal Rates of the Pharmacological Management of Chronic Spinal Cord Injury Pain: A Systematic Review and Meta-Analysis

    DesfavorávelMetanáliseDorDor — Neuropatia PeriféricaLesões da Medula Espinhal
  260. 2021

    The endocannabinoid system - current implications for drug development

    FavorávelMetanáliseDorDependência — CannabisTEPTAnandamida (AEA)Tetraidrocanabinol (THC)+1
  261. 2021

    The Endocannabinoid System Contributes to Electroacupuncture Analgesia

    FavorávelMetanáliseDorInflamaçãoDor — Aguda
  262. 2021

    The terpenes camphene and alpha-bisabolol inhibit inflammatory and neuropathic pain via Cav3.2 T-type calcium channels

    FavorávelEstudo em AnimaisDorInflamaçãoDor — Neuropatia Periférica+1
  263. 2021

    Transcriptomic Profiling in Mice With CB1 receptor Deletion in Primary Sensory Neurons Suggests New Analgesic Targets for Neuropathic Pain

    FavorávelEstudo em AnimaisDorInflamaçãoDor — AgudaEndocanabinoide (não especificado)Canabinoides Sintéticos AM-x+1
  264. 2021

    Treating pain related to Ehlers-Danlos syndrome with medical cannabis

    FavorávelMetanáliseDorDor — AgudaSíndrome de Ehlers-Danlos
  265. 2021

    Values and preferences towards medical cannabis among people living with chronic pain: a mixed-methods systematic review

    InconclusivoMetanáliseDor
  266. 2021

    Within-subject, double-blinded, randomized, and placebo-controlled evaluation of the combined effects of the cannabinoid dronabinol and the opioid hydromorphone in a human laboratory pain model

    FavorávelEnsaio Clínico Duplo-CegoDorDor — AgudaTHC Farmacêutico
  267. 2020

    A Balanced Approach for Cannabidiol Use in Chronic Pain

    InconclusivoMetanáliseDor
  268. 2020

    A Large-Scale Naturalistic Examination of the Acute Effects of Cannabis on Pain

    FavorávelMetanáliseDorDor — AgudaDor — Neuropatia Periférica+1
  269. 2020

    A Literature Analysis on Medicinal Use and Research of Cannabis in the Meiji Era of Japan

    FavorávelMetanáliseDorDoenças NeurodegenerativasInsônia e Distúrbios do Sono+3
  270. 2020

    A Review of Scientific Evidence for THC:CBD Oromucosal Spray (Nabiximols) in the Management of Chronic Pain

    FavorávelMetanáliseDorTHC:CBD Farmacêutico
  271. 2020

    A Scoping Review on Clinical Trials of Pain Reduction With Cannabis Administration in Adults

    InconclusivoMetanálise ClínicaDorEsclerose MúltiplaDor — Aguda+3
  272. 2020

    A Secondary Analysis from a Randomized Trial on the Effect of Plasma Tetrahydrocannabinol Levels on Pain Reduction in Painful Diabetic Peripheral Neuropathy

    FavorávelMetanálise ClínicaDorDiabetesDor — Neuropatia DiabéticaTetraidrocanabinol (THC)
  273. 2020

    Altered gut microbiota and endocannabinoid system tone in vitamin D deficiency-mediated chronic pain

    FavorávelEstudo em AnimaisDorDesequilíbrio do MicrobiomaAnandamida (AEA)Endocanabinoide (não especificado)+4
  274. 2020

    An Analysis of the Putative CBD Binding Site in the Ionotropic Cannabinoid Receptors

    FavorávelEstudo LaboratorialDorInflamação
  275. 2020

    An evaluation of the anti-hyperalgesic effects of cannabidiolic acid-methyl ester in a preclinical model of peripheral neuropathic pain

    FavorávelEstudo em AnimaisDorDor — Neuropatia PeriféricaÁcido Canabidiólico (CBD-a)
  276. 2020

    Analgesic Effects and Impairment in Locomotor Activity Induced by Cannabinoid/Opioid Combinations in Rat Models of Chronic Pain

    FavorávelEstudo em AnimaisDorCanabinoides Sintéticos WIN-x
  277. 2020

    Analgesic Effects of Cannabinoids for Chronic Non-cancer Pain: a Systematic Review and Meta-Analysis with Meta-Regression

    FavorávelMetanálise ClínicaDor
  278. 2020

    Cannabidiol (CBD) as a treatment of acute and chronic back pain: A case series and literature review

    FavorávelMetanáliseDorDor — Aguda
  279. 2020

    Cannabidiol: A Brief Review of Its Therapeutic and Pharmacologic Efficacy in the Management of Joint Disease

    FavorávelMetanáliseDorDor — AgudaArtrite+1
  280. 2020

    Cannabinoid Receptors and Their Relationship With Chronic Pain: A Narrative Review

    FavorávelMetanáliseDorInflamaçãoArtrite+1
  281. 2020

    Cannabinoids in Chronic Non-Cancer Pain: A Systematic Review and Meta-Analysis

    FavorávelMetanáliseDor
  282. 2020

    Cannabinoids in the Treatment of Back Pain

    FavorávelMetanáliseDorDependência — Opioides
  283. 2020

    Cannabis and Vulvodynia Symptoms: A Preliminary Report

    FavorávelMetanáliseDorMenopausa
  284. 2020

    Cannabis sativa: Much more beyond Δ 9-tetrahydrocannabinol

    FavorávelMetanáliseDorEpilepsiaDoenças Neurodegenerativas+1
  285. 2020

    Cannabis treatment in hospitalized patients using the SYQE inhaler: Results of a pilot open-label study

    FavorávelEnsaio ClínicoDorEsclerose MúltiplaNáusea e VômitoTetraidrocanabinol (THC)Canabinol (CBN)+3
  286. 2020

    Cannabis treatment in hospitalized patients using the SYQE inhaler: Results of a pilot open-label study

    FavorávelEnsaio ClínicoDor
  287. 2020

    CBD Effects on TRPV1 Signaling Pathways in Cultured DRG Neurons

    FavorávelEstudo LaboratorialDorDor — Aguda
  288. 2020

    CBD for the treatment of pain: What is the evidence?

    InconclusivoMetanáliseDorDor — Aguda
  289. 2020

    Cholesterol regulates cannabinoid analgesia through glycine receptors

    FavorávelEstudo em AnimaisDorDor — Aguda
  290. 2020

    Effect of Inhaled Cannabis for Pain in Adults With Sickle Cell Disease

    FavorávelEnsaio Clínico Duplo-CegoDorDependência — OpioidesDor — Aguda+1
  291. 2020

    Endocannabinoids release after Osteopathic Manipulative Treatment. A brief review

    FavorávelMetanáliseDorEndocanabinoide (não especificado)Medicina Mente-Corpo
  292. 2020

    Evaluation of the preclinical analgesic efficacy of naturally derived, orally administered oil forms of Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and their 1:1 combination

    FavorávelEstudo em AnimaisDorInflamaçãoDor — Neuropatia PeriféricaTetraidrocanabinol (THC)Ácido Canabidiólico (CBD-a)+1
  293. 2020

    Increased Anandamide and Decreased Pain and Depression after Exercise in Fibromyalgia

    FavorávelEnsaio ClínicoDorDepressãoFibromialgiaAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+1
  294. 2020

    Mapping cannabis potency in medical and recreational programs in the United States

    DesfavorávelMetanáliseDorAnsiedadeDepressãoTetraidrocanabinol (THC)+4
  295. 2020

    Measuring the placebo effect in carpal tunnel syndrome

    FavorávelEnsaio Clínico Duplo-CegoDorDor — Neuropatia PeriféricaArtritePalmitoiletanolamida (PEA)+1
  296. 2020

    Medical cannabinoids and their indications in chronic pain

    FavorávelMetanáliseDor
  297. 2020

    Medical cannabis and cognitive performance in middle to old adults treated for chronic pain

    FavorávelMetanáliseDorDisfunção Cognitiva
  298. 2020

    Medical cannabis and insomnia in older adults with chronic pain: a cross-sectional study

    InconclusivoMetanáliseDorInsônia e Distúrbios do Sono
  299. 2020

    Medical Cannabis as an Alternative for Opioids for Chronic Pain: A Case Report

    FavorávelMetanáliseDor
  300. 2020

    Medical cannabis for orthopaedic patients with chronic musculoskeletal pain: does evidence support its use?

    FavorávelMetanáliseDor
  301. 2020

    Orally consumed cannabinoids provide long-lasting relief of allodynia in a mouse model of chronic neuropathic pain

    FavorávelEstudo em AnimaisDor
  302. 2020

    Recreational Cannabis Use Before and After Legalization in Women With Pelvic Pain

    FavorávelMetanáliseDor
  303. 2020

    The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial

    FavorávelEnsaio Clínico Duplo-CegoDor
  304. 2020

    Use of Cannabis for Self-Management of Chronic Pelvic Pain

    FavorávelMetanáliseDor
  305. 2019

    A Cost-Effectiveness Model for Adjunctive Smoked Cannabis in the Treatment of Chronic Neuropathic Pain

    InconclusivoMetanáliseDor
  306. 2019

    Cannabinoids, cannabis, and cannabis-based medicine for pain management: a protocol for an overview of systematic reviews and a systematic review of randomised controlled trials

    InconclusivoMetanálise ClínicaDor
  307. 2019

    Cannabis Use Preferences and Decision-making Among a Cross-sectional Cohort of Medical Cannabis Patients with Chronic Pain

    InconclusivoMetanáliseDor
  308. 2019

    Cannabis-based medicines for chronic pain management: current and future prospects

    FavorávelMetanáliseDor
  309. 2019

    Cannabis-derived medicines for the treatment of chronic pain : Problems resulting from medical appraisals in the experience of the Medical Advisory Board of the Statutory Health Insurance Funds North

    FavorávelMetanáliseDor
  310. 2019

    Effects of Cannabinoid Administration for Pain: A Meta-Analysis and Meta-Regression

    FavorávelMetanáliseDor
  311. 2019

    Evidence of the efficacy and safety of cannabis medicines for chronic pain management : A methodological minefield

    FavorávelMetanáliseDor
  312. 2019

    High-Frequency Medical Cannabis Use Is Associated With Worse Pain Among Individuals With Chronic Pain

    InconclusivoMetanáliseDorEfeitos Adversos da Cannabis
  313. 2019

    Is there a relationship between cannabis use problems, emotion dysregulation, and mental health problems among adults with chronic pain?

    DesfavorávelMetanáliseDorDependência QuímicaEfeitos Adversos da Cannabis+1
  314. 2019

    Medical cannabis for chronic pain: can it make a difference in pain management?

    FavorávelMetanáliseDor
  315. 2019

    Medical Cannabis for the Treatment of Chronic Pain: A Review of Clinical Effectiveness and Guidelines

    FavorávelMetanáliseDor
  316. 2019

    Mental health functioning and severity of cannabis withdrawal among medical cannabis users with chronic pain

    InconclusivoMetanáliseDorDependência — Cannabis
  317. 2019

    Patients' and clinicians' perspectives of co-use of cannabis and opioids for chronic non-cancer pain management in primary care

    InconclusivoMetanáliseDor
  318. 2019

    Pills to Pot: Observational Analyses of Cannabis Substitution Among Medical Cannabis Users With Chronic Pain

    FavorávelMetanáliseDor
  319. 2019

    Restored Self: A Phenomenological Study of Pain Relief by Cannabis

    FavorávelMetanáliseDor
  320. 2019

    Spontaneous, anecdotal, retrospective, open-label study on the efficacy, safety and tolerability of cannabis galenical preparation (Bedrocan)

    FavorávelEnsaio ClínicoDor
  321. 2018

    Cannabis and cannabinoids for the treatment of people with chronic non-cancer pain conditions: a systematic review and meta-analysis of controlled and observational studies.

    FavorávelMetanáliseDor
  322. 2016

    The Effect of Medicinal Cannabis on Pain and Quality-of-Life Outcomes in Chronic Pain: A Prospective Open-label Study.

    FavorávelEnsaio ClínicoDor
  323. 2016

    β-caryophyllene, a dietary cannabinoid, complexed with β-cyclodextrin produced anti-hyperalgesic effect involving the inhibition of Fos expression in superficial dorsal horn

    FavorávelEstudo em AnimaisDor
  324. 2015

    Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials

    FavorávelMetanálise ClínicaDor
  325. 2009

    Systematic review and meta-analysis of cannabis treatment for chronic pain

    FavorávelMetanálise ClínicaDorTetraidrocanabinol (THC)
  326. 2006

    Evaluation of herbal cannabis characteristics by medical users: a randomized trial

    DesfavorávelEnsaio Clínico Duplo-CegoDor
  327. 2003

    Cannabis Reduces Opioid Dose in the Treatment of Chronic Non-Cancer Pain.

    FavorávelMetanáliseDorTetraidrocanabinol (THC)
  328. 2001

    Tetrahydrocannabinol for treatment of chronic pain

    InconclusivoMetanálise ClínicaDorTetraidrocanabinol (THC)

Continue por aqui

Canabinoides e compostos

THC Farmacêutico 52THC:CBD Farmacêutico 49Tetraidrocanabinol (THC) 43Palmitoiletanolamida (PEA) 39Anandamida (AEA) 33Endocanabinoide (não especificado) 312-Araquidonoilglicerol (2-AG) 26CBD Farmacêutico 20

Sistemas do corpo

Sistema Nervoso 253Saúde Mental e Emocional 54Sistema Esquelético 32Sistema Digestório 12Sistema Muscular 12Sistema Endócrino 7

Perguntas frequentes

Quantos estudos sobre dor — crônica estão indexados no acervo?
São 508 estudos, publicados entre 1849 e 2024. O acervo inteiro tem 7.640 registros.
Que tipos de estudo predominam?
Metanálise: 294 · Estudo em Animais: 62 · Ensaio Clínico: 52 · Metanálise Clínica: 45 · Ensaio Clínico Duplo-Cego: 42 · Estudo Laboratorial: 13. A classificação segue o desenho declarado na fonte.
O que significa a classificação de resultado?
É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 400 favoráveis, 75 inconclusivos e 33 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. Dor — Crônica — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/condicao/dor-cronica/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). Dor — Crônica — estudos científicos sobre cannabis. https://cannabisindica.com.br/condicao/dor-cronica/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.